HIGHLIGHTS
- who: Naoyuki Miyashita and colleagues from the Division of Respiratory Medicine, Infectious Disease and Allergology, First Department of Internal Medicine, Kansai Medical University, Shinmachi, Hirakata, Osaka, Japan have published the research work: Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia, in the Journal: (JOURNAL) of 18/01/2022
- what: The aim of this study was to clarify the clinical and radiological differences of the CAP and coronavirus disease 2019 (COVID-19) CAP. This study was conducted at five institutions (Kansai Medical University Hospital, Kansai Medical University Medical Center, Kansai Medical University . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.